ORIC
Oric Pharmaceuticals, Inc. · Healthcare · Market cap $1.4B
Insiders sold $1.2M net in the last 90 days ·2 sellers, 0 buyers· 3 of 3 sales under Rule 10b5-1 plans· latest Form 4 filed Aug 28, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$4.2M
reported sales (SEC code S)
Unique Insiders
4
in the rolling window
Latest filing
Aug 28, 2026
Piscitelli Dominic
Oric Pharmaceuticals, Inc. (ORIC) has 14 SEC Form 4 filings (26 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Aug 28, 2026.
Inside the rolling window, 4 insiders at Oric Pharmaceuticals, Inc. reported no open-market purchases and 12 open-market sales totaling $4.2M. The most active filer is Chief Financial Officer Piscitelli Dominic with 4 filings. Insiders have net sold $1.2M over the trailing 6 months. The most recent open-market filing is a sale of 77,000 shares by Chief Financial Officer Piscitelli Dominic, dated Aug 26, 2026, worth $1.1M.
- Industry:Biotechnology
- CEO:Jacob Chacko
- Employees:122
- HQ:South San Francisco, CA, US
- IPO:2020-04-24
| Source | |||||||
|---|---|---|---|---|---|---|---|
Piscitelli DominicFirst in 6 months | Chief Financial Officer | Sale | 77,000 | $1.1M | Aug 28 | +2.0% | SEC ↗ |
| Director | Sale | 13,100 | $157K | Jul 28 | +13.4% | SEC ↗ | |
Heyman Richard A.First in 5 months | Director | Sale | 300 | $4K | Jul 8 | +23.9% | SEC ↗ |
| Chief Financial Officer | Sale | 52,000 | $703K | Feb 26 | +0.0% | SEC ↗ | |
| Director | Sale | 6,700 | $80K | Jan 20 | +16.2% | SEC ↗ | |
Multani Pratik SFirst filing | Chief Medical Officer | Sale | 10,720 | $97K | Dec 17 | +64.2% | SEC ↗ |
| PRESIDENT AND CEO | Sale | 33,374 | $302K | Dec 17 | +64.2% | SEC ↗ | |
| Chief Financial Officer | Sale | 10,720 | $97K | Dec 17 | +64.2% | SEC ↗ | |
Piscitelli DominicFirst filing | Chief Financial Officer | Sale | 11,000 | $160K | Oct 8 | — | SEC ↗ |
| PRESIDENT AND CEO | Sale | 37,461 | $462K | Oct 8 | — | SEC ↗ | |
Chacko JacobFirst filing | PRESIDENT AND CEO | Sale | 34,538 | $415K | Oct 2 | — | SEC ↗ |
Chacko JacobFirst filing | PRESIDENT AND CEO | Sale | 53,001 | $639K | Oct 2 | — | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does ORIC have?
Oric Pharmaceuticals, Inc. (ORIC) has 14 SEC Form 4 filings (26 transaction rows) in the rolling 365-day window, disclosed by 4 distinct insiders. Most recent filing: Aug 28, 2026.
When was the most recent SEC Form 4 filing for ORIC?
The most recent Form 4 filing for ORIC on Tracefour is dated Aug 28, 2026.
Who is the most active insider at ORIC?
The most active SEC Form 4 filer at ORIC in the rolling window is Chief Financial Officer Piscitelli Dominic, with 4 filings.
What is the net insider flow at ORIC over the last 6 months?
Over the trailing 180 days, insiders at ORIC have net sold $1.2M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at ORIC in the current window?
Inside the rolling window, insiders at ORIC bought $0 and sold $4.2M based on SEC Form 4 filings.
Can I get alerts for ORIC insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Oric Pharmaceuticals, Inc. (ORIC). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Oric Pharmaceuticals, Inc. is in the Healthcare sector.